MUNTEANU A

Last name: MUNTEANU A

2005 (v1)

Publication

Metadata-only

CD36 overexpression in ritonavir-treated THP-1 cells is reversed by alpha-tocopherol.

MUNTEANU A ZINGG JM RICCIARELLI, ROBERTA

Therapies with antiretroviral protease inhibitors (ARPI) are correlated with a higher risk for dyslipidemia, hypercholesterolemia, and atherosclerosis. The original aim of this study was to establish whether a-tocopherol can reduce CD36 scavenger receptor overexpression occurring after treatment of monocytes with the ARPI ritonavir.We show here...

Uploaded on: May 13, 2023
2004 (v1)

Publication

Metadata-only

HIV protease inhibitors-induced atherosclerosis: prevention by alpha-tocopherol.

MUNTEANU A RICCIARELLI, ROBERTA ZINGG JM

No description

Uploaded on: April 14, 2023
2007 (v1)

Publication

Metadata-only

Modulation of proteasome activity by vitamin E in THP-1 monocytes.

MUNTEANU A RICCIARELLI, ROBERTA MASSONE S

No description

Uploaded on: March 27, 2023
2008 (v1)

Publication

Metadata-only

Characterization of three human sec14p-like proteins: alpha-Tocopherol transport activity and expression pattern in tissues.

ZINGG JM KEMPNA P PARIS M

Three closely related human sec14p-like proteins (hTAP1, 2, and 3, or SEC14L2, 3, and 4, respectively) have been described. These proteins may participate in intracellular lipid transport (phospholipids, squalene, tocopherol analogues and derivatives) or influence regulatory lipiddependent events. Here, we show that the three recombinant hTAP...

Uploaded on: March 27, 2023

MUNTEANU A

Recent uploads